** = Publikationen gelistet in SCI/SSCI/Pubmed
** Ulrich, S; Meitz, S; Posch, U; Schlenke, P
Characterization of three novel HLA class I alleles, HLA-A*31:01:02:56, HLA-B*35:588 and HLA-B*57:153.
HLA. 2024; 103(1):e15338
Doi: 10.1111/tan.15338
Web of Science
PubMed
FullText
FullText_MUG
** Sperl, D; Benesch, M; Posch, U; Rosskopf, K; Strenger, V; Tschauner, S; Seidel, MG; Schwinger, W
SUCCESSFUL THIRD ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING TWO GRAFT REJECTIONS IN A PATIENT WITH CHRONIC GRANULOMATOUS DISEASE AND HEPATIC/PARAPHRENIC ABSCESSES
BONE MARROW TRANSPL. 2024; 59: 416-416.-50th EBMT Annual Meeting; APR 14-17, 2024; Glasgow, SCOTLAND.
[Poster]
Web of Science
** Ulrich, S; Lang, J; Bodem, O; Posch, U; Schlenke, P
Identification of the novel HLA-B*51:01:01:78 allele and confirmation of extended sequence of B*18:01:26
HLA. 2022;
Doi: 10.1111/tan.14536
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Amenitsch, J; Eller, K; Pollheimer, MJ; Posch, U; Zitta, S
ACUTE HUMORAL REJECTION AFTER ABO INCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATION
HLA. 2022; 100: 11-11.
[Poster]
Web of Science
** Amenitsch, J; Eller, K; Pollheimer, MJ; Zitta, S; Posch, U.
Acute humoral rejection after ABO incompatible living donor kidney transplantation despite favorable isoagglutinin titre
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 3):224-225.
[Poster]
Web of Science
** Ulrich, S; Lang, J; Posch, U; Schlenke, P
Identification of the novel HLAC*03:03:01:52N allele and confirmation of HLAC*03:03:01:50, renamed HLA-C*03:03:01:50N
HLA. 2022; 99(5): 541-541.
[Poster]
Web of Science
** Ulrich, S; Lang, J; Posch, U; Schlenke, P
Characterization of the novel HLA-C*14:124 allele by next generation sequencing.
HLA. 2021; 13(2):
Doi: 10.1111/tan.14216
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ulrich, S; Lang, JN; Bodem, O; Posch, U; Schlenke, P
Identification of the novel HLA-C*03:03:01:52N allele, a splice-site variant at the boundary of intron1 and exon2
HLA. 2021;
Doi: 10.1111/tan.14454
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ulrich, S; Ladstatter, S; Posch, U; Schlenke, P
Identification of the novel HLA-C*07:02:01:115 allele in a volunteer bone marrow donor
HLA. 2021;
Doi: 10.1111/tan.14330
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rosskopf, K; Sipurzynski, S; Posch, U; Schwinger, W; Torreiter, P; Kovacic, K; Schlenke, P
RED BLOOD CELL DEPLETION OF BONE MARROW: COMPARISON OF TWO CELL SEPARATORS AND FIRST EXPERIENCE WITH SMALL VOLUME GRAFTS
TRANSPL INT. 2018; 31: 20-20.
[Oral Communication]
Web of Science
** Ulrich, S; Matzhold, E; Posch, U; Schlenke, P; Helmberg, W
HLA-DRB3*02:61Q , a novel HLA-DRB3 allele identified in a volunteer bone marrow donor.
HLA. 2017; 90(3):186-187
Doi: 10.1111/tan.13061
Web of Science
PubMed
FullText
FullText_MUG
** Ulrich, S; Matzhold, EM; Posch, U; Schlenke, P; Helmberg, WM
IDENTIFICATION OF A NOVEL HLA-DRB3 ALLELE
HLA. .. 2017; 89(6):471-471.
[Poster]
Web of Science
** Ulrich, S; Posch, U; Helmberg, W; Schlenke, P
HLA-A*68:02:11, a new HLA-A*68 allele identified during family HLA typing.
HLA. 2016; 88(4):197-198
Doi: 10.1111/tan.12875
Web of Science
PubMed
FullText
FullText_MUG
** Macher, S; Zinke-Cerwenka, W; Posch, U; Ulrich, S; Sipurzynski, S; Greinix, H; Schlenke, P
Thrombozytenrefraktärität durch Anti-HPA 3a bei Zustand nach allogener Blutstammzelltransplantation: ein Fallbericht.
TRANSPL INT. . 2016; 29(s4):21-21.-Austrostransplant 2016; OCT 19-21, 2016; Schladming, AUSTRIA.
[Poster]
Web of Science
** Tobias, N; Martini, CV; Renner, W; Posch, U; Schaffellner, S; Stauber, R; Muller, H; Kniepeiss, D
EVALUATION OF DONOR AND RECEPTOR PNPLA3 (RS738409) -POLYMORPHISM DURING LIVER TRANSPLANTATION
TRANSPL INT. 2016; 29: 12-12.-Austrotransplant 2016; 19 - 21 OCT, 2016;
[Poster]
Web of Science
** Ulrich, S; Posch, U; Helmberg, W; Schlenke, P
A NOVEL HLA -A ALLELE: HLA A-A*68:02:11
HLA. 2016; 87(4):291-291.
[Poster]
Web of Science
** Sareban, N; Macher, S; Drexler, C; Posch, U; Lanzer, G; Schallmoser, K
Platelet antibody analysis by three different tests.
J Clin Lab Anal. 2015; 29(3):198-202
Doi: 10.1002/jcla.21750
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ulrich, S; Posch, U; Lanzer, G;
THE NOVEL HLA-A* ALLELE A*32:53 IDENTIFIED BY SEQUENCE BASED TYPING.
TISSUE ANTIGEN. 2014; 84(1):111-111.-28th EFI European Immunogenetics and Histocompatibility Conference; JUN 25-28, 2014; Stockholm, SWEDEN.
[Poster]
Web of Science
** Finkenstedt, A; Auer, C; Glodny, B; Posch, U; Steitzer, H; Lanzer, G; Pratschke, J; Biebl, M; Steurer, M; Graziadei, I; Vogel, W; Zoller, H
Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis.
Clin Gastroenterol Hepatol. 2013; 11(12):1667-1672
Doi: 10.1016/j.cgh.2013.06.025
Web of Science
PubMed
FullText
FullText_MUG
** Ulrich, S; Posch, U; Lanzer, G
Detection of a new HLA-A allele, designated HLA-A*32:53.
Tissue Antigens. 2013; 82(5):348-348
Doi: 10.1111/tan.12205
Web of Science
PubMed
FullText
FullText_MUG
** Ulrich, S; Dauber, EM; Posch, U; Steitzer, HJ; Lanzer, G; Mayr, WR;
SUSPECTED UNEQUAL CROSSING OVER ON SHORT ARM OF CHROMOSOME 6-A CASE REPORT.
TISSUE ANTIGEN. 2013; 81(5):357-358.-27th Annual EFI European Immunogenetics and Histocompatibility Conference; MAY 11-14, 2013; Maastricht, NETHERLANDS.
[Poster]
Web of Science
** Rosenmayr, A; Pointner-Prager, M; Mitterschiffthaler, A; Bozic, L; Pelzmann, B; Tüchler, H; Fae, I; Fischer, GF; Greinix, HT; Peters, Ch; Kalhs, P; Krieger, O; Linkesch, W; Nachbaur, D; Urban, Ch; Posch, U; Lanzer, G; Gabriel, Ch; Schennach, H; Mayr, WR
What are a patient's current chances of finding a matched unrelated donor? Twenty years' central search experience in a small country.
Bone Marrow Transplant. 2012; 47(2):172-180
Doi: 10.1038/bmt.2011.67
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Finkenstedt, A; Posch, U; Steitzer, H; Lanzer, G; Pratschke, J; Graziadei, I; Vogel, W; Zoller, HM
The PNPLA3 I148M genotype is more frequent in liver transplant recipients than in organ donors and is a predictor of posttransplant survival
HEPATOLOGY. 2012; 56: 282A-283A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
[Poster]
Web of Science
** Lindner, E; Weger, M; Steinwender, G; Griesbacher, A; Posch, U; Ulrich, S; Wegscheider, B; Ardjomand, N; El-Shabrawi, Y
IL2RA gene polymorphism rs2104286 A>G seen in multiple sclerosis is associated with intermediate uveitis: possible parallel pathways?
Invest Ophthalmol Vis Sci. 2011; 52(11):8295-8299
Doi: 10.1167/iovs.11-8163
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zinke-Cerwenka, W; Valentin, A; Posch, U; Beham-Schmid, C; Groselj-Strele, A; Linkesch, W; Wölfler, A; Sill, H
Reduced-intensity allografting in patients with therapy-related myeloid neoplasms and active primary malignancies.
Bone Marrow Transplant. 2011; 46(12):1540-1544
Doi: 10.1038/bmt.2011.165
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Posch, U; Ulrich, S; Rohde, E; Lanzer, G
Graft versus host disease after liver transplantation
TISSUE ANTIGEN. . 2011; 77(5):455-456.-25th European Immunogenetics and Histocompatibility Conference; MAY 4-7, 2011; Prague, Czech Republic.
[Poster]
Web of Science
** Ulrich, S; Posch, U; Drexler, C; Steitzer, H; Lanzer, G
Human chimerism suspected in a phenotypically normal man due to HLA typing: a case report
TISSUE ANTIGEN. . 2011; 77(5):481-481.-25th European Immunogenetics and Histocompatibility Conference; MAY 4-7, 2011; Prague, Czech Republic.
[Poster]
Web of Science
** Zinke-Cerwenka, W; Rohn, A; Posch, U; Beham-Schmid, C; Linkesch, W; Wölfler, A; Sill, H
Graft-versus-primary malignancy in patients with therapy-related myeloid neoplasms (t-MNs) undergoing reduced-intensity allogeneic hematopoietic stem cell transplantation (HSCT).
Onkologie. 2011; 34(6):274-274.-Jahrestagung der DÖuSGHO; SEP 30-OCT 04, 2011; Basel.
[Poster]
Web of Science
** Amrein, K; Posch, U; Langner, C; Gorkiewicz, G; Högenauer, C
Transfusion-associated graft-versus-host disease presenting as severe high-volume diarrhoea in a patient with Goodpasture's syndrome.
Intensive Care Med. 2010; 36(7):1271-1272
Doi: 10.1007/s00134-010-1881-x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Ulrich, S; Sorantin, S; Posch, U; Helmberg, W; Lanzer, G
A new HLA-A*26 variant, A*2637 identified by haplotype-specific extraction and sequencing-based typing.
TISSUE ANTIGEN. 2009; 73(3): 275-276.
Doi: 10.1111/j.1399-0039.2008.01202.x
Web of Science
PubMed
FullText
FullText_MUG
** Posch, U; Ulrich, S; Schwinger, W; Lanzer, G
Alternative family donors for hematopoietic stem cell transplantation
TISSUE ANTIGEN. 2009; 73(5):444-444.-23rd European Immunogenetics and Histocompatibility Conference; MAY 09-12, 2009; Ulm, GERMANY.
[Oral Communication]
Web of Science
** Posch, U; Zinke-Cerwenka, W; Ulrich, S; Schallmoser, K; Drexler, C; Lanzer, G
HLA alloimmunization and unrelated hematopoietic stem cell transplantation - two case reports
TISSUE ANTIGEN. 2009; 73(5):444-445.-23rd European Immunogenetics and Histocompatibility Conference; MAY 09-12, 2009; Ulm, GERMANY.
[Poster]
Web of Science
** Ulrich, S; Sorantin, S; Posch, U; Helmberg, W; Lanzer, G
A new HLA-A*26 variant, A*2637 identified by haplotype specific extraction and sequencing based typing
TISSUE ANTIGEN. 2009; 73(5):512-512.-23rd European Immunogenetics and Histocompatibility Conference; MAY 09-12, 2009; Ulm, GERMANY.
[Poster]
Web of Science
** Ulrich, S; Posch, U; Helmberg, W; Lanzer, G
A new HLA-B*44 variant, B*4453, identified by haplotype-specific extraction and sequencing-based typing.
Tissue Antigens. 2008; 71(1):91-92
Doi: 10.1111/j.1399-0039.2007.00951.x
Web of Science
PubMed
FullText
FullText_MUG
** Posch, U
Umbilical cord blood transplantations for adults with high risk hematologic malignancies
TISSUE ANTIGEN. 2008; 71(4):329-329.
[Poster]
Web of Science
** Reitter, S; Posch, U; Eibl, M; Sill, H; Linkesch, W; Zinke-Cerwenka, W
NONMYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH RICHTER SYNDROME: A REPORT OF TWO CASES
HAEMATOL-HEMATOL J. 2008; 93: 1410--13th Congress of the European-Hematology-Association; JUN 12-15, 2008; Copenhagen, DENMARK.
[Poster]
Web of Science
** Zinke-Cerwenka, W; Posch, U; Sill, H; Eibl, E; Linkesch, W
FOLLOW-UP OF PATIENTS WITH MULTIPLE MYELOMA UNDERGOING AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION (PBSCT) FOLLOWED BY REDUCED-INTENSITY ALLOGENEIC PBSCT
HAEMATOL-HEMATOL J. 2008; 93: 1435
[Poster]
Web of Science
** Zinke-Cerwenka, W; Posch, U; Zebisch, A; Linkesch, W; Sill, H
Results of umbilical cord blood transplantations in adults with high-risk haematologic malignancies
BONE MARROW TRANSPLANT. BONE MARROW TRANSPLANTATION.2008; 41: S158-S158.-34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group; MAR 30-APR 02, 2008; Florence, ITALY.
[Poster]
Web of Science
** Amrein, K; Posch, U; Lanzer, G; Hogenauer, C
Fatal transfusion associated graftversus host disease in goodpastures syndrome treated with cyclophosphamide
HAEMATOL-HEMATOL J. 2007; 92: 312-312.
[Poster]
Web of Science
** Posch, U; Amrein, K; Ulrich, S; Hogenauer, C; Gorkiewicz, G; Langner, C; Lanzer, G
Fatal transfusion associated graft-versus-host disease in Goodpasture's Syndrome - a case report
TISSUE ANTIGEN. 2007; 69(5):454-455.-21st European Immunogenetics and Histocompatibility Conference; MAY 5 - 8, 2007; Barcelona, SPAIN.
[Poster]
Web of Science
** Ulrich, S; Posch, U; Lanzer, G
Confirmation of B*0710 and determination of the sequence of exon 4
TISSUE ANTIGEN. 2007; 69(5):406-406.
[Oral Communication]
Web of Science
** Zinke-Cerwenka, W; Scheidl, S; Eibl, M; Posch, U; Linkesch, W
Incidence of late-onset noninfectious pulmonary complications in allogeneic stem cell transplantation with non-myeloablative conditioning based on fludarabine/TBI or fludarabine/melphalan
BONE MARROW TRANSPLANT. 2007; 39: S295-S295.
[Poster]
Web of Science
** El-Shabrawi, Y; Wegscheider, BJ; Weger, M; Renner, W; Posch, U; Ulrich, S; Ardjomand, N; Hermann, J
Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
OPHTHALMOLOGY. 2006; 113(4): 695-700.
Doi: 10.1016/j.ophtha.2006.01.004
Web of Science
PubMed
FullText
FullText_MUG
** Drexler, C; Posch, U; Ulrich, S; Helmberg, W; Lanzer, G
Monitoring of sCD30 in patients prior to kidney transplantation (KTx)
TISSUE ANTIGEN. ; 67: 506-506.-20th European Immunogenetics and Histocompatibility Conference; JUN 8-11, 2006; Oslo, NORWAY.
[Poster]
Web of Science
** Posch, U; Ulrich, S; Helmberg, W; Lanzer, G
Peripheral blood stem cell mobilization with G-CSF: long term follow up of unrelated allogeneic donors
TISSUE ANTIGEN. 67: 517-517.
[Poster]
Web of Science
** Posch, U; Ulrich, S; Zinke-Cerwenka, W; Sorantin, S; Helmberg, W; Lanzer, G
Incidence of anti HLA immunization after allogeneic stem cell transplantation
TISSUE ANTIGEN. 67: 502-503.
[Poster]
Web of Science
** Ulrich, S; Posch, U; Heimberg, W; Lanzer, G
Confirmation of A*020109 using HaploPrepTM for HLA-A and determination of the associated haplotype
TISSUE ANTIGEN. 67: 470-470.
[Poster]
Web of Science
** Macher, S; Schallmoser, K; Staber, PB; Neumeister, P; Posch, U; Lanzer, G; Panzer, S
Severe thrombocytopenia due to host-derived anti-HPA-1a after non-myeloablative allogeneic haematopoietic stem cell transplantation for multiple myeloma: a case report.
VOX SANG. 2005; 89(4): 257-260.
Doi: 10.1111/j.1423-0410.2005.00692.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Wegscheider, BJ; Weger, M; Renner, W; Posch, U; Ulrich, S; Hermann, J; Ardjomand, N; Haller-Schober, EM; El-Shabrawi, Y
Role of the CCL2/MCP-1 -2518A>G gene polymorphism in HLA-B27 associated uveitis.
MOL VIS. 2005; 11(9-10): 896-900.
[OPEN ACCESS]
Web of Science
PubMed
** Macher, S; Schallmoser, K; Staber, P; Neumeister, P; Rosskopf, K; Posch, U; Panzer, S; Lanzer, G
Severe immune thrombocytopenia due to HPA-1 a host-derived antibodies after non-myeloablative allogeneic hematopoetic stem cell transplantation for multiple myeloma
TRANSFUSION 2005 45: 114A-114A.
Web of Science
** Schallmoser, K; Kutschera, J; Macher, S; Posch, U; Panzer, S; Lanzer, G
A case of neonatal alloimmune thrombocytopenia likely caused by anti-HPA-3a
TRANSFUSION 2005 45: 116A-116A.
Web of Science
** Posch, U; Ulrich, S; Lanzer, G
Donors' experiences of unrelated allogeneic bone marrow versus peripheral blood stem cell donation
GENES IMMUN 2004 5: S29-S29.
Web of Science
** Ulrich, S; Posch, U; Lanzer, G
Determination of the sequence of exon 4 of HLA B*0809
GENES IMMUN 2004 5: S73-S73.
Web of Science
** Rosskopf, K; Sipurzynski, S; Gilli, R; Posch, U; Olipitz, W; Linkesch, W; Gehrer, M; Wagner, T; Lanzer, G
Marked reduction of bacterial contamination rate in peripheral blood progenitor cell concentrates after installation of a labaratory according to GMP
BONE MARROW TRANSPLANT. 2003; 31: S200-S200.
Web of Science
** Ulrich, S; Posch, U; Lanzer, G
HLA A*, B*, DRB1*SSP-low resolution typing of cord blood samples using diluted DNA prepared with the GenoM (TM)-6 automated system
GENES IMMUN 2003 4: S63-S63.
Web of Science
** Gilli, R; Macher, S; Posch, U; Rosskopf, K; Schallmoser, K; Sipurzynski, S; Wagner, T; Wasler, A; Tscheliessnigg, K; Lanzer, G
Feasibility of extracorporal photopheresis in patients after heart transplantation
TRANSFUSION 2001 41: 43S-43S.
Web of Science
** Schallmoser, K; Wagner, T; Rosskopf, K; Macher, S; Posch, U; Gilli, R; Sipurzynski, S; Lanzer, G
Alloimmunization after RhD-incompatible platelet transfusions
TRANSFUSION. 2001; 41: 105S-105S.-54th Annual Meeting; OKT 13-17, 2001; San Antonio, TX, USA.
Web of Science
** Luxenberger, W; Posch, U; Berghold, A; Hofmann, T; Lang-Loidolt, D
HLA patterns in patients with nasal polyposis.
Eur Arch Otorhinolaryngol. 2000; 257(3):137-139
Doi: 10.1007/s004050050210
Web of Science
PubMed
FullText
FullText_MUG
** Gilli, R; Helmberg, W; Posch, U; Sipurzynski, S; Schwinger, W; Urban, C; TruschnigWilders, M; Lanzer, G
Stem cell separations in pediatric patients weighing less than 20 kg
BRIT J HAEMATOL 1996 93: 911-911.
Web of Science
** Kulier, AH; Gombotz, H; Fuchs, G; Vuckovic, U; Metzler, H
Subcutaneous recombinant human erythropoietin and autologous blood donation before coronary artery bypass surgery.
Anesth Analg. 1993; 76(1):102-106
Doi: 10.1213/00000539-199301000-00018
Web of Science
PubMed
FullText
FullText_MUG